Cardiovascular disease

Area of Science:

• Cardiovascular Health
• Health Economics
• Preventive Medicine

Background:

• Coronary heart disease (CHD) is a leading cause of mortality, responsible for significant healthcare burdens.
• Preventive strategies targeting CHD risk factors are crucial for public health.
• The economic value of preventing CHD deaths and improving quality of life is substantial.

Purpose of the Study:

• To estimate the cost-effectiveness of screening for and preventing coronary heart disease risk factors.
• To identify barriers to implementing effective CHD prevention strategies.
• To highlight the potential impact of prevention on reducing annual mortality.

Main Methods:

• Economic analysis of screening and prevention programs for CHD risk factors.
• Review of existing literature on CHD prevention costs and outcomes.
• Estimation of potential mortality reduction based on implemented prevention.

Main Results:

• The cost of gaining one quality-adjusted life year (QALY) through CHD risk factor screening and prevention ranges from £550 to £960.
• This represents a highly cost-effective intervention according to established thresholds.
• An estimated 180,000 deaths could be prevented annually through widespread implementation.

Conclusions:

• Screening for and preventing coronary heart disease risk factors is a cost-effective strategy.
• The significant potential to avert premature deaths underscores the need for improved implementation.
• Addressing barriers to prevention is critical to realize the full public health benefits.